Show source-provided references
2. Codario, R. (2011). Pathophysiology of Type-2 Diabetes. Type 2 Diabetes, Pre-Diabetes, and the Metabolic Syndrome, Humana Press.
10.1007/978-1-60327-441-8 ↗4. Putting the pieces of the puzzle together—A series of hypotheses on the etiology and pathogenesis of type 1 diabetes
10.1016/j.mehy.2006.07.052 ↗6. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema
10.2337/dc15-1585 ↗7. Bonora, E., and DeFronzo, R. (2018). Diagnostic Criteria and Classification. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Springer International Publishing.
10.1007/978-3-319-27317-4 ↗8. Gliclazide mainly affects insulin secretion in second phase of type 2 diabetes mellitus
10.1055/s-2001-15411 ↗10. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: Dose association with all-cause mortality, cardiovascular events and cancer
10.1111/dom.12412 ↗13. Beta cell antigens in type 1 diabetes: Triggers in pathogenesis and therapeutic targets
10.3410/B2-75 ↗15. Insulin replacement therapy. Minimizing complications and side effects
16. Bonora, E., and DeFronzo, R. (2018). Insulin Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Springer International Publishing.
10.1007/978-3-319-27317-4 ↗17. Islet cell therapy and pancreatic stem cells
19. Quality of Life After Islet Transplantation
21. Clatworthy, M., Watson, C., Allison, M., and Dark, J. (2012). Transplantation at a Glance, John Wiley & Sons, Incorporated.
25. Piemonti, L., Socci, C., Nano, R., Maffi, P., and Secchi, A. (2018). Islet Cell or Pancreas Transplantation. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Bonora, E., DeFronzo, R., Eds., Springer International Publishing.
10.1007/978-3-319-27317-4_23-1 ↗27. Pareta, R., McQuilling, J.P., Farney, A.C., and Opara, E.C. (2012). Bioartificial Pancreas: Evaluation of Crucial Barriers to Clinical Application. Organ Donation and Transplantation-Public Policy and Clinical Perspectives, IntechOpen Limited.
10.5772/32648 ↗34. Diabetes mellitus: An overview on its pharmacological aspects and reported medicinal plants having antidiabetic activity
10.1016/S2221-1691(12)60067-7 ↗35. Bonora, E., and DeFronzo, R. (2018). Epidemiology and Risk Factors of Type 2 Diabetes. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Springer International Publishing.
10.1007/978-3-319-27317-4 ↗36. Bonora, E., and DeFronzo, R. (2018). Epidemiology and Risk Factors of Type 1 Diabetes. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Springer International Publishing.
10.1007/978-3-319-27317-4 ↗37. Federation, I.D. (2019). IDF Diabetes Atlas. IDF Diabetes Atlas. Brussels, Belgium: International Diabetes Federation, International Diabetes Federation (IDF).
39. Pickup, J.C. (2018). Insulin Pumps. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment, Bonora, E., DeFronzo, R., Eds., Springer International Publishing.
10.1007/978-3-319-27317-4_22-1 ↗43. Review article: The emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non-alcoholic fatty liver disease
10.1111/apt.12084 ↗45. Mikov, M., Al-Salami, H., and Golocorbin-Kon, G. (2012). Potentials and Limitations of Bile Acids and Probiotics in Diabetes Mellitus, IntechOpen Limited.
10.5772/20553 ↗47. Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes
10.1111/jdi.13293 ↗50. Potentials and Limitations of Bile Acids in Type 2 Diabetes Mellitus: Applications of Microencapsulation as a Novel Oral Delivery System
52. Chang, T.M.S. (2007). Artificial Cells: Biotechnology, Nanomedicine, Regenerative Medicine, Blood Substitutes, Bioencapsulation, and Cell/Stem Cell Therapy, World Scientific.
10.1142/9789812770370 ↗53. Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment
10.3109/02652048.2014.958204 ↗54. Probucol Release from Novel Multicompartmental Microcapsules for the Oral Targeted Delivery in Type 2 Diabetes
10.1208/s12249-014-0205-9 ↗55. Microencapsulation as a novel delivery method for the potential antidiabetic drug, Probucol
56. Stability and Release Kinetics of an Advanced Gliclazide-Cholic Acid Formulation: The Use of Artificial-Cell Microencapsulation in Slow Release Targeted Oral Delivery of Antidiabetics
10.1007/s12247-014-9182-5 ↗57. Alginate-microencapsulation of human stem cell–derived β cells with CXCL 12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression
10.1111/ajt.15308 ↗58. Advanced bile acid-based multi-compartmental microencapsulated pancreatic beta-cells integrating a polyelectrolyte-bile acid formulation, for diabetes treatment
10.3109/21691401.2014.971806 ↗60. Hardikar, A.A. (2016). The Pathobiology of Diabetes Mellitus. Pancreatic Islet Biology, Springer International Publishing.
10.1007/978-3-319-45307-1 ↗61. Da Silva Xavier, G. (2018). The Cells of the Islets of Langerhans. J. Clin. Med., 7.
10.3390/jcm7030054 ↗62. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: Mechanism of action
10.2337/diabetes.50.6.1302 ↗67. Ulloa-Aguirre, A., and Conn, P.M. (2014). Cellular Endocrinology in Health and Disease, Elsevier Science & Technology.
69. Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion
10.1038/s41598-020-79992-7 ↗71. Encapsulation of RIN-m5F cells within Ba2+ cross-linked alginate beads affects proliferation and insulin secretion
10.1080/02652040600789245 ↗74. Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: Special reference to expression of glucose transporter isoforms
10.1210/endo-127-1-126 ↗77. Morphological and functional characterization of beta TC-6 cells-an insulin-secreting cell line derived from transgenic mice
10.2337/diab.44.3.306 ↗79. Viability and Functions of Alginate-microencapsulated Islets Isolated from Neonatal Pigs. Asian-Australas
81. The effects of alginate encapsulation on NIT-1 insulinoma cells: Viability, growth and insulin secretion
85. Toward Engineering a Novel Transplantation Site for Human Pancreatic Islets
10.2337/db12-1553 ↗87. Development of human fetal pancreas after transplantation into SCID mice
10.1159/000047830 ↗88. Development of a conditionally immortalized human pancreatic beta cell line
10.1172/JCI72674 ↗89. A genetically engineered human pancreatic β cell line exhibiting glucose-inducible insulin secretion
10.1172/JCI58447 ↗90. The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates
10.1016/j.molmet.2017.12.007 ↗93. Cell-cell communication mimicry with poly(ethylene glycol) hydrogels for enhancing beta-cell function
10.1073/pnas.1014026108 ↗95. Microencapsulation of a hydrophilic model molecule through vibration nozzle and emulsion phase inversion technologies
10.3109/02652048.2013.764938 ↗96. A review on ionotropic gelation method: Novel approach for controlled gastroretentive gelispheres
97. Microencapsulation of Coenzyme Q10 and bile acids using ionic gelation vibrational jet flow technology for oral delivery
10.4155/tde-2020-0082 ↗98. Micro-Nano formulation of bile-gut delivery: Rheological, stability and cell survival, basal and maximum respiration studies
10.1038/s41598-020-64355-z ↗100. An advanced microencapsulated system: A platform for optimized oral delivery of antidiabetic drug-bile acid formulations
10.3109/10837450.2014.915570 ↗